Trial NCT01575899

View at ClinicalTrials.gov 
Org. Study IDs: IRB096-28

Last trial update was posted on 2012-08-31

MeSH Interventions

Amoxicillin Amoxicillin-Potassium Clavulanate Combination Clarithromycin Clavulanic Acid Levofloxacin Ofloxacin Rabeprazole

MeSH Conditions


Other Conditions

Helicobacter Pylori Infection

Stopping Reasons

Early termination due to efficacy

Limitations And Caveats

The limitation of this study is the local primary resistance of Hp to levofloxacin and to amoxicillin/clavulanate is unknown. We are currently engaged in an on-going investigation of the influence of CYP2C19 genotypes on this new regimen.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID